111 related articles for article (PubMed ID: 9499162)
1. A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins.
Butterfield DA; Martin L; Carney JM; Hensley K
Life Sci; 1996; 58(3):217-28. PubMed ID: 9499162
[TBL] [Abstract][Full Text] [Related]
2. beta-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease.
Butterfield DA; Hensley K; Harris M; Mattson M; Carney J
Biochem Biophys Res Commun; 1994 Apr; 200(2):710-5. PubMed ID: 8179604
[TBL] [Abstract][Full Text] [Related]
3. Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity.
Kanski J; Varadarajan S; Aksenova M; Butterfield DA
Biochim Biophys Acta; 2002 Mar; 1586(2):190-8. PubMed ID: 11959460
[TBL] [Abstract][Full Text] [Related]
4. Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition.
Koppal T; Subramaniam R; Drake J; Prasad MR; Dhillon H; Butterfield DA
Brain Res; 1998 Mar; 786(1-2):270-3. PubMed ID: 9555054
[No Abstract] [Full Text] [Related]
5. New evidence that the Alzheimer beta-amyloid peptide does not spontaneously form free radicals: an ESR study using a series of spin-traps.
Turnbull S; Tabner BJ; El-Agnaf OM; Twyman LJ; Allsop D
Free Radic Biol Med; 2001 May; 30(10):1154-62. PubMed ID: 11369506
[TBL] [Abstract][Full Text] [Related]
6. The pyrrolopyrimidine U101033E is a potent free radical scavenger and prevents Fe(II)-induced lipid peroxidation in synaptosomal membranes.
Lauderback CM; Breier AM; Hackett J; Varadarajan S; Goodlett-Mercer J; Butterfield DA
Biochim Biophys Acta; 2000 Jun; 1501(2-3):149-61. PubMed ID: 10838188
[TBL] [Abstract][Full Text] [Related]
7. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
Hensley K; Carney JM; Mattson MP; Aksenova M; Harris M; Wu JF; Floyd RA; Butterfield DA
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3270-4. PubMed ID: 8159737
[TBL] [Abstract][Full Text] [Related]
8. Direct evidence of oxidative injury produced by the Alzheimer's beta-amyloid peptide (1-40) in cultured hippocampal neurons.
Harris ME; Hensley K; Butterfield DA; Leedle RA; Carney JM
Exp Neurol; 1995 Feb; 131(2):193-202. PubMed ID: 7895820
[TBL] [Abstract][Full Text] [Related]
9. Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease.
Koppal T; Drake J; Yatin S; Jordan B; Varadarajan S; Bettenhausen L; Butterfield DA
J Neurochem; 1999 Jan; 72(1):310-7. PubMed ID: 9886083
[TBL] [Abstract][Full Text] [Related]
10. A spectroscopic study of some of the peptidyl radicals formed following hydroxyl radical attack on beta-amyloid and alpha-synuclein.
Tabner BJ; Turnbull S; King JE; Benson FE; El-Agnaf OM; Allsop D
Free Radic Res; 2006 Jul; 40(7):731-9. PubMed ID: 16984000
[TBL] [Abstract][Full Text] [Related]
11. The lipid peroxidation product, 4-hydroxy-2-trans-nonenal, alters the conformation of cortical synaptosomal membrane proteins.
Subramaniam R; Roediger F; Jordan B; Mattson MP; Keller JN; Waeg G; Butterfield DA
J Neurochem; 1997 Sep; 69(3):1161-9. PubMed ID: 9282939
[TBL] [Abstract][Full Text] [Related]
12. The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease.
Subramaniam R; Koppal T; Green M; Yatin S; Jordan B; Drake J; Butterfield DA
Neurochem Res; 1998 Nov; 23(11):1403-10. PubMed ID: 9814551
[TBL] [Abstract][Full Text] [Related]
13. In vivo protection by the xanthate tricyclodecan-9-yl-xanthogenate against amyloid beta-peptide (1-42)-induced oxidative stress.
Perluigi M; Joshi G; Sultana R; Calabrese V; De Marco C; Coccia R; Butterfield DA
Neuroscience; 2006; 138(4):1161-70. PubMed ID: 16427207
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive study on the generation of reactive oxygen species in Cu-Aβ-catalyzed redox processes.
Huang H; Lou X; Hu B; Zhou Z; Chen J; Tian Y
Free Radic Biol Med; 2019 May; 135():125-131. PubMed ID: 30849487
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta-peptide spin trapping. II: Evidence for decomposition of the PBN spin adduct.
Hensley K; Aksenova M; Carney JM; Harris M; Butterfield DA
Neuroreport; 1995 Feb; 6(3):493-6. PubMed ID: 7766851
[TBL] [Abstract][Full Text] [Related]
16. Amyloid beta-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease.
Butterfield DA; Yatin SM; Varadarajan S; Koppal T
Methods Enzymol; 1999; 309():746-68. PubMed ID: 10507060
[TBL] [Abstract][Full Text] [Related]
17. Prevention of hyperoxia-induced alterations in synaptosomal membrane-associated proteins by N-tert-butyl-alpha-phenylnitrone and 4-hydroxy-2,2,6,6-tetramethylpiperidin-1-oxyl (Tempol).
Howard BJ; Yatin S; Hensley K; Allen KL; Kelly JP; Carney J; Butterfield DA
J Neurochem; 1996 Nov; 67(5):2045-50. PubMed ID: 8863512
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42).
Yatin SM; Varadarajan S; Link CD; Butterfield DA
Neurobiol Aging; 1999; 20(3):325-30; discussion 339-42. PubMed ID: 10588580
[TBL] [Abstract][Full Text] [Related]
19. Cupric-amyloid beta peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical.
Dikalov SI; Vitek MP; Mason RP
Free Radic Biol Med; 2004 Feb; 36(3):340-7. PubMed ID: 15036353
[TBL] [Abstract][Full Text] [Related]
20. Amyloid beta-peptide spin trapping. I: Peptide enzyme toxicity is related to free radical spin trap reactivity.
Hensley K; Aksenova M; Carney JM; Harris M; Butterfield DA
Neuroreport; 1995 Feb; 6(3):489-92. PubMed ID: 7766850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
